• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型桃金娘烯醛类似物作为DNA促旋酶和拓扑异构酶IV抑制剂的发现、合成及抗菌活性

Discovery, synthesis, and antibacterial activity of novel myrtucommulone analogs as inhibitors of DNA gyrase and topoisomerase IV.

作者信息

Yang Hao, Li Jian, Wang Bo-Lin, Yang Xin-Ya, Zhang Yu

机构信息

School of Pharmacy, Ningxia Medical University, Yinchuan, 750004, China.

School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China.

出版信息

Eur J Med Chem. 2025 Feb 5;283:117138. doi: 10.1016/j.ejmech.2024.117138. Epub 2024 Dec 8.

DOI:10.1016/j.ejmech.2024.117138
PMID:39662286
Abstract

Drug-resistant bacterial infections have emerged as a new challenge in anti-infective treatment, posing a significant threat to public health. DNA gyrase and topoisomerase IV (Topo IV) are promising targets for designing new antibiotics. Myrtus communis L. has long been used as a traditional herb for antisepsis and disinfection; however, the underlying mechanism of the antibacterial activity remains unclear. In this study, a class of novel myrtucommulone derivatives was synthesized and evaluated for DNA gyrase and Topo IV inhibitions. Analog 27 was the most potent DNA gyrase and Topo IV inhibitor. In bioactivity assays, molecule 27 exhibited a significant antibacterial effect against methicillin-resistant Staphylococcus aureus (MRSA). Additionally, it exhibited rapid bactericidal properties, low toxicity, and low inducing bacterial resistance. It demonstrated synergistic effects with ofloxacin, amikacin, cefepime, and ceftazidime, which make it a potential candidate for antimicrobial application. This work will facilitate the future development of myrtucommulone-based DNA gyrase and Topo IV inhibitors as novel antimicrobials to combat the increasing prevalence of multidrug-resistant bacteria.

摘要

耐药细菌感染已成为抗感染治疗中的一项新挑战,对公众健康构成重大威胁。DNA旋转酶和拓扑异构酶IV(Topo IV)是设计新型抗生素的有前景的靶点。香桃木长期以来一直被用作防腐消毒的传统草药;然而,其抗菌活性的潜在机制仍不清楚。在本研究中,合成了一类新型桃金娘烯酮衍生物,并评估了它们对DNA旋转酶和Topo IV的抑制作用。类似物27是最有效的DNA旋转酶和Topo IV抑制剂。在生物活性测定中,分子27对耐甲氧西林金黄色葡萄球菌(MRSA)表现出显著的抗菌作用。此外,它还具有快速杀菌特性、低毒性和低诱导细菌耐药性。它与氧氟沙星、阿米卡星、头孢吡肟和头孢他啶表现出协同作用,这使其成为抗菌应用的潜在候选物。这项工作将促进基于桃金娘烯酮的DNA旋转酶和Topo IV抑制剂作为新型抗菌剂的未来开发,以应对多药耐药细菌日益普遍的情况。

相似文献

1
Discovery, synthesis, and antibacterial activity of novel myrtucommulone analogs as inhibitors of DNA gyrase and topoisomerase IV.新型桃金娘烯醛类似物作为DNA促旋酶和拓扑异构酶IV抑制剂的发现、合成及抗菌活性
Eur J Med Chem. 2025 Feb 5;283:117138. doi: 10.1016/j.ejmech.2024.117138. Epub 2024 Dec 8.
2
Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV.新型喹啉-1,3,4-噁二唑和喹啉-1,2,4-三唑杂合体的设计、合成及抗菌活性评价,作为 DNA 回旋酶和拓扑异构酶 IV 的潜在抑制剂。
Bioorg Chem. 2021 Jul;112:104920. doi: 10.1016/j.bioorg.2021.104920. Epub 2021 Apr 19.
3
Synthesis of novel 2-aminobenzothiazole derivatives as potential antimicrobial agents with dual DNA gyrase/topoisomerase IV inhibition.合成新型 2-氨基苯并噻唑衍生物作为潜在的抗菌剂,具有双重 DNA 拓扑异构酶/拓扑异构酶 IV 抑制作用。
Bioorg Chem. 2020 Jan;94:103437. doi: 10.1016/j.bioorg.2019.103437. Epub 2019 Nov 23.
4
Discovery of aminopiperidine based potent & novel topoisomerase inhibitor with broad spectrum anti-bacterial activity.发现具有广谱抗菌活性的基于氨基哌啶的新型拓扑异构酶抑制剂。
Bioorg Med Chem Lett. 2024 Oct 1;111:129911. doi: 10.1016/j.bmcl.2024.129911. Epub 2024 Jul 26.
5
Dual inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV activity by phenylalanine-derived (Z)-5-arylmethylidene rhodanines.苯丙氨酸衍生的(Z)-5-芳基亚甲基硫代罗丹宁对金黄色葡萄球菌DNA促旋酶和拓扑异构酶IV活性的双重抑制作用
Bioorg Med Chem. 2015 Sep 15;23(18):6125-37. doi: 10.1016/j.bmc.2015.08.004. Epub 2015 Aug 14.
6
Discovery of novel 1,4-dicarbonylthiosemicarbazides as DNA gyrase inhibitors for the treatment of MRSA infection.发现新型 1,4-二羰基硫代缩氨基脲类化合物作为 DNA 拓扑异构酶抑制剂用于治疗耐甲氧西林金黄色葡萄球菌感染。
Eur J Med Chem. 2024 Dec 15;280:116905. doi: 10.1016/j.ejmech.2024.116905. Epub 2024 Sep 28.
7
Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.新型3-氟-6-甲氧基喹啉衍生物作为细菌DNA促旋酶和拓扑异构酶IV的抑制剂
Bioorg Med Chem Lett. 2017 Aug 1;27(15):3353-3358. doi: 10.1016/j.bmcl.2017.06.009. Epub 2017 Jun 3.
8
Improved N-phenylpyrrolamide inhibitors of DNA gyrase as antibacterial agents for high-priority bacterial strains.作为高优先级细菌株的抗菌剂,改进的 N- 苯基吡咯烷酰胺类 DNA 拓扑异构酶抑制剂。
Eur J Med Chem. 2024 Nov 15;278:116823. doi: 10.1016/j.ejmech.2024.116823. Epub 2024 Sep 1.
9
Action mechanism of 6, 6'-dihydroxythiobinupharidine from Nuphar japonicum, which showed anti-MRSA and anti-VRE activities.来自日本萍蓬草的6,6'-二羟基硫代去甲斑蝥素的作用机制,其具有抗耐甲氧西林金黄色葡萄球菌(MRSA)和抗耐万古霉素肠球菌(VRE)活性。
Biochim Biophys Acta. 2015 Jun;1850(6):1245-52. doi: 10.1016/j.bbagen.2015.02.012. Epub 2015 Feb 27.
10
New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens.新型双重 ATP 竞争型细菌 DNA 回旋酶和拓扑异构酶 IV 抑制剂,对 ESKAPE 病原体有效。
Eur J Med Chem. 2021 Mar 5;213:113200. doi: 10.1016/j.ejmech.2021.113200. Epub 2021 Jan 22.

引用本文的文献

1
In Search of New Drugs: Elucidating the Activity of Structurally Similar Potential Antibiotics Using Molecular Modelling.寻找新型药物:利用分子建模阐明结构相似的潜在抗生素的活性
Molecules. 2025 Jul 10;30(14):2920. doi: 10.3390/molecules30142920.
2
The Next Frontier: Unveiling Novel Approaches for Combating Multidrug-Resistant Bacteria.下一个前沿领域:揭示对抗多重耐药细菌的新方法。
Pharm Res. 2025 Jun 16. doi: 10.1007/s11095-025-03871-x.